269K Followers 597 FollowingCell aims to publish the most exciting and provocative research in biology. Posts by Scientific Editors on the Cell Editorial team.
4.7M Followers 458 FollowingCutting-edge research, news, commentary, and visuals from the Science family of journals. Follow @NewsfromScience for stories from our News team.
53K Followers 4K FollowingThe room where bio partnerships get made. Pharma BD, corporate venture, and 2,000 founders — all in San Jose, May 4–7.
https://t.co/mdobxJzlQf
14K Followers 309 FollowingWe provide in-depth insight into the most significant news and trends shaping biotech and pharma. Sign up here: https://t.co/sTgs1kxwYE
8K Followers 126 FollowingAt Editas Medicine, we are harnessing the potential of CRISPR gene editing to develop medicines for people living with serious diseases
7K Followers 88 FollowingAbCellera is clinical-stage biotech company focused developing antibody-based medicines in the areas of endocrinology, women’s health, immunology and oncology
10K Followers 480 FollowingInsilico Medicine is a clinical-stage AI-driven biotech company dedicated to extending human productive longevity by transforming drug discovery with AI.
3K Followers 1 Following-Bioquímica y catedrática
-Actual Premio Nobel de Química por el desarrollo de un método para la edición genética
-Cuenta creada con fines educativos
69K Followers 3K Following@ArcInstitute co-founder, @Stanford professor, @ThriveCapital investor | biology and ML research | 🇨🇦 prev @harvard @broadinstitute, Fast Grants
37K Followers 2K FollowingMy posts are strictly personal, not reflective of positions or policies of Insilico Medicine, which disclaims any responsibility for my individual statements.
30K Followers 5 FollowingFounder and CEO of @insitro, Machine Learning pioneer, co-founder of Coursera, adjunct CS Professor at Stanford, avid traveler
1.1M Followers 172 FollowingNobel Laureate. Co-Founder & CEO @GoogleDeepMind - working on AGI. Solving disease @IsomorphicLabs. Trying to understand the fundamental nature of reality.